World's Best Scientists 2026 revealed!
Award Badge
Biology and Biochemistry
USA
2023

D-Index & Metrics

Biology and Biochemistry

D-Index
85
Citations
24374
World Ranking
3169
National Ranking
1598

David Baker publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where David Baker sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 358 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

David Baker D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where David Baker sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 85 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Biology and Biochemistry in United States Leader Award
  • 2021 - Breakthrough Prize in Life Sciences for developing technology that allowed the design of proteins never seen before in nature, including novel proteins that have the potential for therapeutic intervention in human diseases.
  • 2020 - Fellow of the Indian National Academy of Engineering (INAE)
  • 2009 - Fellow of the American Academy of Arts and Sciences
  • 2006 - Member of the National Academy of Sciences

Overview

David Baker is affiliated with the University of Washington in the United States and focuses primarily on medicine, with a significant number of publications in pathology and forensic medicine, immunology, molecular biology, oncology, and infectious diseases. Their research spans multiple topics, particularly in multiple sclerosis studies, COVID-19 and SARS-CoV-2 research, immunotherapy and immune responses, polyomavirus-related diseases, peripheral neuropathies and disorders, neurogenesis and neuroplasticity mechanisms, and monoclonal and polyclonal antibodies research.

Several recent papers by David Baker include the following:

  • COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases, 2020, Clinical & Experimental Immunology
  • The ocrelizumab phase II extension trial suggests the potential to improve the risk: benefit balance in multiple sclerosis, 2020, Multiple Sclerosis and Related Disorders

They have frequently collaborated with researchers such as Gavin Giovannoni, Klaus Schmierer, Angray S. Kang, Sharmilee Gnanapavan, and Mónica Marta.

Their work has been published extensively in venues including Multiple Sclerosis and Related Disorders, bioRxiv (Cold Spring Harbor Laboratory), Clinical & Experimental Immunology, Journal of Neurology Neurosurgery & Psychiatry, and Human Antibodies.

David Baker's contributions are recognized through several awards, such as the Breakthrough Prize in Life Sciences in 2021 for developing technology that enabled the design of novel proteins with potential therapeutic applications. Additional honors include being named a Fellow of the Indian National Academy of Engineering (INAE) in 2020, a Fellow of the American Academy of Arts and Sciences in 2009, and a Member of the National Academy of Sciences since 2006.

Best Publications

  • Inflammation in neurodegenerative diseases

    Sandra Amor;Sandra Amor;Fabiola Puentes;David Baker;Paul van der Valk

  • Pharmaco-metabonomic phenotyping and personalized drug treatment.

    T. Andrew Clayton;John C. Lindon;Olivier Cloarec;Henrik Antti

  • Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism

    T. Andrew Clayton;David Baker;John C. Lindon;Jeremy R. Everett

  • Cannabinoids control spasticity and tremor in a multiple sclerosis model.

    D Baker;G Pryce;J L Croxford;P Brown

  • Inflammation in neurodegenerative diseases – an update

    Sandra Amor;Sandra Amor;Laura A. N. Peferoen;Daphne Y. S. Vogel;Marjolein Breur

  • IMMUNOHISTOCHEMICAL LOCALIZATION OF CANNABINOID TYPE 1 AND VANILLOID TRANSIENT RECEPTOR POTENTIAL VANILLOID TYPE 1 RECEPTORS IN THE MOUSE BRAIN

    L. Cristino;L. de Petrocellis;G. Pryce;D. Baker

  • The therapeutic potential of cannabis

    David Baker;Gareth Pryce;Gavin Giovannoni;Alan J Thompson

  • Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice.

    S Amor;N Groome;C Linington;M M Morris

  • Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells.

    Katarzyna Maresz;Gareth Pryce;Gareth Pryce;Eugene D Ponomarev;Giovanni Marsicano

  • Cannabinoids inhibit neurodegeneration in models of multiple sclerosis

    Gareth Pryce;Zubair Ahmed;Deborah J. R. Hankey;Samuel J. Jackson

  • In silico patent searching reveals a new cannabinoid receptor.

    David Baker;Gareth Pryce;Wayne L. Davies;C. Robin Hiley

  • Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors

    Aymen I Idris;Aymen I Idris;Robert J van 't Hof;Robert J van 't Hof;Iain R Greig;Susan A Ridge

  • Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins.

    David Baker;Debra Butler;Bernard J. Scallon;Janet K. O'Neill

  • Two years later: journals are not yet enforcing the ARRIVE guidelines on reporting standards for pre-clinical animal studies.

    David Baker;Katie Lidster;Ana Sottomayor;Sandra Amor

  • Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus.

    Antonella Napolitano;Sam Miller;Andrew W. Nicholls;David Baker

  • Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis

    John Greenwood;Claire E. Walters;Gareth Pryce;Naheed Kanuga

  • Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis

    David Baker;Monica Marta;Gareth Pryce;Gavin Giovannoni

  • MicroRNA-155 negatively affects blood–brain barrier function during neuroinflammation

    Miguel Alejandro Lopez-Ramirez;Dongsheng Wu;Gareth Pryce;Julie E. Simpson

  • Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice

    D. Baker;J.K. O'Neill;S.E. Gschmeissner;C.E. Wilcox

  • Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab.

    David Baker;Samuel S. Herrod;Cesar Alvarez-Gonzalez;Gavin Giovannoni;Gavin Giovannoni

Frequent Co-Authors

Gavin Giovannoni
Gavin Giovannoni Queen Mary University of London
Gareth Pryce
Gareth Pryce Queen Mary University of London
Frank DiMaio
Frank DiMaio University of Washington
Sandra Amor
Sandra Amor University of Amsterdam
Gaetano T. Montelione
Gaetano T. Montelione Rensselaer Polytechnic Institute
Brian Kuhlman
Brian Kuhlman University of North Carolina at Chapel Hill
Tanja Kortemme
Tanja Kortemme University of California, San Francisco
William R. Schief
William R. Schief Scripps Research Institute
Rong Xiao
Rong Xiao Rutgers, The State University of New Jersey
Todd O. Yeates
Todd O. Yeates University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry opens doors to diverse opportunities in healthcare, research, and management. As industries evolve, more students and professionals are considering flexible online degree options to advance their careers.

If you are interested in healthcare leadership, explore online mha programs cahme accredited for a rigorous path in healthcare administration. For those aiming for advanced nursing roles but needing flexibility, consider online dnp programs that do not require clinical hours.

Individuals seeking top-level managerial positions may pursue the best doctorate of healthcare administration programs. For biochemistry graduates interested in pharmacy practice, several online pharm d programs offer flexibility for working professionals.

Online degrees make it easier to balance education with work or family while preparing for emerging careers in science, healthcare, and management.

Best Scientists Citing David Baker

Trending Scientists

Recently Published Articles